US PhRMA not ready to give up on FDA FY13 user fees
This article was originally published in SRA
Executive Summary
The US research-based pharmaceutical industry association, PhRMA, has made it clear that it is not ready to throw in the towel on efforts to ensure that the Food and Drug Administration receives the prescription drug user fees for fiscal year 20131,2.